MedTrace Logo

Same-Day Discharge After Coronary Percutaneous Transluminal Coronary Angioplasty (PTCA)

NCT01068119 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2013-09-23

No results posted yet for this study

Summary

Same day discharge is safe and feasible in selected troponin negative patients undergoing coronary planned percutaneous coronary intervention (PCI) or ad hoc PCI via the transfemoral approach.

Conditions

  • Acute Coronary Syndrome

Interventions

PROCEDURE

Same-day discharge

Patients identified as clinically stable are discharged home the same day as the PCI procedure with telephone follow-up at 12 hr, 24 hr, 3, 30, 180 and 365 days post procedure.

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Piedmont Healthcare

    lead OTHER

Principal Investigators

  • Dimitrios Karmpaliotis, MD, PhD · Piedmont Heart Institute/Piedmont Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2011-08-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01068119 on ClinicalTrials.gov